AM-PHARMA
Dead / Abandoned — Abandoned — failure to respond (as of 19 Jan 2023)
What this means for you
This application is over — abandoned 09 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79311483
- Mark type
- Stylized text
- Filed
- 28 Jan 2021
- Abandoned
- 09 Jan 2023
- Attorney of record
- James C. Watson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, medical and veterinary preparations for the treatment and prevention of kidney diseases and kidney dysfunction; plasters for medical purposes, adhesive bandages; disinfectants; dietary supplements for medical purposes; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of kidney disease and kidney dysfunction; pharmaceutical drugs for the treatment of kidney diseases and kidney dysfunction; pharmaceutical preparations to treat kidney diseases and kidney dysfunction
- Class 042 — Scientific and technological services: Scientific and technological services, as well as research and design related thereto , in the field of kidney disease and kidney dysfunction; research in the scientific, technological and industrial fields in the field of kidney disease and kidney dysfunction; industrial analysis and industrial research services in the field of kidney disease and kidney dysfunction; development of technologies, diagnostics, drugs, personal care products, and devices for others in the field of kidney disease and kidney dysfunction; biotechnological research in the field of enzymatic synthesis; testing, authentication and quality control; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; pharmaceutical research; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical development of drugs; testing of pharmaceutical products; pharmaceutical drug development services; consulting in the field of pharmaceutical research; clinical research and research in the medical field relating to kidney disease and kidney dysfunction; scientific research for medical purposes, namely, conducting clinical trials; conducting clinical trials for others in the field of pharmaceutical products for the treatment of kidney disease and kidney dysfunction
- Class 044 — Medical, beauty and agricultural services: Provision of short-term care medical services in intensive care units and hospitals; services of hygiene and beauty care for people; consultancy and information related to short-term care biopharmaceutical products provided in intensive care units and hospitals; short-term care pharmaceutical consultancy provided in intensive care units and hospitals; provision of news and information in the field of short-term care medicines provided in intensive care units and hospitals; medical services for diagnosis of diseases of the human body provided in intensive care units and hospitals
Owner
- AM-Pharma B.V., NL
Prosecution history
- 13 Feb 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Jan 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Jan 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 19 Jan 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 19 Jan 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 19 Jan 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 14 Nov 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 26 Oct 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 26 Oct 2022 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 07 Jul 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Jul 2022 — NON-FINAL ACTION E-MAILED
- 07 Jul 2022 — NON-FINAL ACTION WRITTEN
- 01 Jun 2022 — ASSIGNED TO EXAMINER
- 25 Mar 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Mar 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE